Rifat Tuly, MPH

We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access

02/22/2021

Marlon Graf , PhD;

T. Joseph Mattingly II, PhD, PharmD, MBA;

Stacey Hickson , PhD;

Jason Shafrin , PhD;

Christoph Glaetzer , Dipl Kfm;

Rifat Tuly , MPH;

Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...

...

02/22/2021

Journal of Clinical Pathways

Pharma Insights

The Complementary Relationship Between Quantitative and Qualitative Research Methods in Enhancing Understanding of Treatment Decisions, Outcomes, and Value Assessment

08/19/2021

Marlon Graf , PhD;

Rifat Tuly , MPH;

Suepattra G. May , MPH, PhD;

Marlon Graf, PhD, and colleagues discuss how evidence generated through a mix of both quantitative and qualitative research methods are necessary in addressing complexity in healthcare innovation and care delivery.

Marlon Graf, PhD, and colleagues...

08/19/2021

Journal of Clinical Pathways